Urinalysis Market Size Projected to Generate a Revenue of $5,719.3 Million by 2031

Download Sample   Reports Overview

The Global Urinalysis Market Size is predicted to be valued at $5,719.3 million by 2031, surging from $3,117.7 million in 2021, at a noteworthy CAGR of 6.4%.

Impact Analysis of COVID-19 on the Urinalysis Market

The impact of COVID-19 on the urinalysis market has been moderate, with a decrease in demand for routine tests but an increase in demand for tests related to COVID-19. The COVID-19 pandemic has had a significant impact on the healthcare industry, including the urinalysis market. Urinalysis is a common diagnostic test used to evaluate the health of the urinary system and detect a range of conditions, including infections, kidney diseases, and diabetes. The COVID-19 pandemic has resulted in significant changes in the way healthcare services are delivered. In many cases, routine medical tests, including urinalysis, were postponed, or canceled as healthcare facilities prioritized resources to address the pandemic. This resulted in a decrease in demand for urinalysis tests. However, the pandemic has also increased the need for urinalysis in certain cases, for COVID-19 patients; moreover, urinalysis can help predict the severity of COVID-19 and identify patients at risk for developing acute kidney injury, a serious complication of the disease. All these factors have affected the urinalysis market growth during the pandemic.

Global Urinalysis Market Analysis

The incidence of chronic kidney diseases (CKDs) is increasing worldwide, which is driving the demand for urinalysis as it is a non-invasive and cost-effective diagnostic tool for detecting kidney diseases. Urinalysis is a simple and non-invasive diagnostic tool that is used to detect various diseases and disorders, including kidney diseases. The growing incidence of CKD is one of the major drivers of the urinalysis market. According to the National Kidney Foundation, CKD affects around 10% of the global population, and it is estimated that around 2 million people worldwide die from CKD-related complications every year. The increasing prevalence of risk factors such as diabetes, hypertension, and obesity, which are major contributors to the development of CKD, is also driving the demand for urinalysis. These are the major factors anticipated to boost the urinalysis market share during the analysis timeframe.

Some individuals may feel uncomfortable providing a urine sample in a public setting, which can further discourage them from participating in urinalysis testing. This can lead to a decrease in demand for urinalysis tests, and ultimately impact the growth of the urinalysis market. Healthcare providers and testing laboratories need to address these privacy concerns by implementing robust data protection policies and ensuring that patient data is securely stored and accessed only by authorized personnel.

The growing geriatric population presents a significant opportunity for the urinalysis market. With an increasing number of elderly patients requiring diagnostic testing, urinalysis is poised to play an increasingly important role in the diagnosis and management of various medical conditions. Moreover, the growing geriatric population and other factors driving the urinalysis market include increasing awareness about preventive healthcare, rising healthcare expenditure, and technological advancements in urinalysis equipment. Urinalysis can help detect these conditions early, allowing healthcare professionals to intervene before the disease progresses and causes serious complications. For example, a urinalysis that detects high levels of glucose may indicate the presence of diabetes, while high levels of protein may indicate kidney disease. These factors are expected to create significant opportunities for market growth.

Global Urinalysis Market, Segmentation

The global urinalysis market is segmented based on product type, application, end-user, and region.

Product Type:

The product type segment is further classified into instruments and consumables. Among these, the consumables sub-segment accounted for the largest market share in 2021 and is expected to continue growing due to the increasing demand for accurate and rapid diagnosis of urinary diseases. Furthermore, the increasing adoption of point-of-care testing (POCT) is also driving the growth of the urinalysis market's consumables segment. POCT allows for quick and accurate diagnosis of urinary tract infections and other urinary diseases, making it an ideal choice for use in emergency rooms, clinics, and other healthcare settings. The adoption of POCT is expected to increase in the future, driving the growth of the urinalysis market's consumables sub-segment.

Application:

The application segment is further classified into disease screening and pregnancy & fertility testing. Among these, the disease screening sub-segment accounted for the largest market share in 2021. Disease screening is one of the key drivers of the urinalysis market. Urinalysis is a routine diagnostic tool used in disease screening programs and is recommended by healthcare organizations for the early detection and management of various diseases. Urinalysis is a diagnostic test that evaluates urine for the presence of abnormalities such as blood, protein, glucose, bacteria, and other substances. According to the World Health Organization (WHO), around 10% of the world's population is affected by chronic kidney disease (CKD), and the number is increasing every year. Urinalysis is a crucial diagnostic tool for the early detection and management of CKD. The disease screening is a crucial segment that drives the growth of the urinalysis market.

End-User:

The end-user segment is further classified into diagnostic laboratories, hospitals & clinics, home care, and others. Among these, the diagnostic laboratories sub-segment accounted for highest revenue share in 2021. The diagnostic laboratories segment of the urinalysis market refers to the segment where urinalysis tests are conducted in medical laboratories. Diagnostic laboratories offer a wide range of urinalysis tests for the diagnosis of various diseases and health conditions. These tests are performed on urine samples collected from patients and can help identify the presence of abnormalities, such as infections, kidney diseases, diabetes, and liver disorders. The demand for urinalysis tests in diagnostic laboratories is driven by the increasing prevalence of chronic diseases, rising awareness about the importance of early disease diagnosis, and the growing adoption of advanced diagnostic technologies.

Region:

The urinalysis market size in the Asia-Pacific region is projected to show the fastest growth. The Asia Pacific region is expected to witness significant growth in the urinalysis market demand due to the increasing prevalence of chronic diseases, growing demand for home-based and point-of-care diagnostic tests, and rising healthcare expenditure. The increasing adoption of advanced technologies and automation in the healthcare industry is also likely to drive the growth of the urinalysis market growth in the region. Moreover, the increasing awareness about the importance of early diagnosis and disease management is expected to boost the demand for urinalysis tests in the region. Moreover, the Asia Pacific region's urinalysis market share is expected to grow due to the increasing burden of chronic diseases, the growing geriatric population, and the rising demand for preventive healthcare and point-of-care testing (POCT) devices.

Key Players in the Global Urinalysis Market

Some of the leading urinalysis market analysis players are

• Abbott
• Sysmex Corporation
• Siemens Healthcare Gmbh
• ACON Laboratories Inc.
• ARKRAY Inc
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• F. Hoffmann-La Roche Ltd
• Quidel Corporation
• Bio-Rad Laboratories Inc
• Teco Diagnostics

For instance, in January 2022, The quantify Advanced Control equipment was introduced by Bio-Rad Laboratories, Inc. to monitor the precision of urinalysis test procedure in clinical labs. This equipment aims to improve the laboratory's statistical process control and product demand in the coming years.